Filing Details

Accession Number:
0001179110-21-001553
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-10 19:07:26
Reporting Period:
2021-02-08
Accepted Time:
2021-02-10 19:07:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1730430 Kiniksa Pharmaceuticals Ltd. KNSA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532218 K Sanj Patel C/o Kiniksa Pharmaceuticals, Ltd.
Clarendon House 2 Church Street
Hamilton D0 HM11
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Shares Acquisiton 2021-02-08 4,924 $1.59 4,924 No 4 M Direct
Class A Common Shares Disposition 2021-02-08 4,924 $23.00 0 No 4 S Direct
Class A Common Shares Acquisiton 2021-02-09 20,401 $1.59 20,401 No 4 M Direct
Class A Common Shares Disposition 2021-02-09 20,401 $23.04 0 No 4 S Direct
Class A Common Shares Disposition 2021-02-08 4,528 $23.00 108,042 No 4 S Indirect Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Shares Disposition 2021-02-09 23,569 $23.08 84,473 No 4 S Indirect Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Shares Acquisiton 2021-02-10 1,600 $1.59 1,600 No 4 M Direct
Class A Common Shares Disposition 2021-02-10 1,600 $23.06 0 No 4 S Direct
Class A Common Shares Disposition 2021-02-10 1,137 $23.07 83,336 No 4 S Indirect Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Indirect Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
No 4 S Indirect Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
No 4 M Direct
No 4 S Direct
No 4 S Indirect Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Shares Share Option Disposition 2021-02-08 4,924 $0.00 4,924 $1.59
Class A Common Shares Share Option Disposition 2021-02-09 20,401 $0.00 20,401 $1.59
Class A Common Shares Share Option Disposition 2021-02-10 1,600 $0.00 1,600 $1.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
347,272 2025-12-15 No 4 M Direct
326,871 2025-12-15 No 4 M Direct
325,271 2025-12-15 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Shares 109,795 Indirect Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
Footnotes
  1. The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.
  2. The option is fully vested and exercisable.
  3. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  4. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.24. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  5. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.02. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  6. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.27. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  7. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  8. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.